Equities research analysts expect that LHC Group, Inc. (NASDAQ:LHCG) will post sales of $511.16 million for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for LHC Group’s earnings, with the highest sales estimate coming in at $516.50 million and the lowest estimate coming in at $494.38 million. LHC Group posted sales of $295.98 million during the same quarter last year, which would indicate a positive year over year growth rate of 72.7%. The firm is scheduled to issue its next quarterly earnings report after the market closes on Wednesday, May 8th.
On average, analysts expect that LHC Group will report full-year sales of $2.11 billion for the current financial year, with estimates ranging from $2.11 billion to $2.13 billion. For the next financial year, analysts forecast that the business will post sales of $2.22 billion, with estimates ranging from $2.19 billion to $2.27 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that follow LHC Group.
LHC Group (NASDAQ:LHCG) last announced its quarterly earnings data on Wednesday, February 27th. The health services provider reported $1.03 EPS for the quarter, meeting the Zacks’ consensus estimate of $1.03. The firm had revenue of $509.80 million for the quarter, compared to analyst estimates of $522.21 million. LHC Group had a return on equity of 8.40% and a net margin of 3.50%. The business’s quarterly revenue was up 75.1% compared to the same quarter last year. During the same period last year, the company earned $0.62 EPS.
Several research analysts have recently issued reports on LHCG shares. Zacks Investment Research lowered LHC Group from a “buy” rating to a “hold” rating in a research report on Wednesday, April 10th. BidaskClub lowered LHC Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 27th. Barclays raised their price target on LHC Group from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 21st. Robert W. Baird raised their price target on LHC Group from $98.00 to $120.00 and gave the stock a “neutral” rating in a research report on Monday, March 4th. Finally, SunTrust Banks raised their price target on LHC Group to $130.00 and gave the stock a “buy” rating in a research report on Friday, March 1st. Six investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. LHC Group presently has an average rating of “Buy” and an average target price of $113.25.
In other LHC Group news, CEO Keith G. Myers sold 75,000 shares of LHC Group stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $108.53, for a total transaction of $8,139,750.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Keith G. Myers sold 11,558 shares of LHC Group stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $108.83, for a total value of $1,257,857.14. Following the transaction, the chief executive officer now owns 96,315 shares in the company, valued at $10,481,961.45. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 192,876 shares of company stock worth $20,614,290. Corporate insiders own 6.80% of the company’s stock.
A number of hedge funds have recently bought and sold shares of the business. BlackRock Inc. lifted its holdings in LHC Group by 2.7% during the fourth quarter. BlackRock Inc. now owns 4,566,337 shares of the health services provider’s stock worth $428,687,000 after acquiring an additional 121,385 shares in the last quarter. FMR LLC lifted its holdings in LHC Group by 24.9% during the fourth quarter. FMR LLC now owns 1,123,833 shares of the health services provider’s stock worth $105,506,000 after acquiring an additional 224,124 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in LHC Group by 2.9% during the third quarter. Bank of New York Mellon Corp now owns 732,075 shares of the health services provider’s stock worth $75,394,000 after acquiring an additional 20,567 shares in the last quarter. Norges Bank bought a new position in LHC Group during the fourth quarter worth about $51,535,000. Finally, Thrivent Financial for Lutherans lifted its holdings in LHC Group by 9.1% during the fourth quarter. Thrivent Financial for Lutherans now owns 530,693 shares of the health services provider’s stock worth $49,822,000 after acquiring an additional 44,450 shares in the last quarter. Hedge funds and other institutional investors own 93.46% of the company’s stock.
LHCG traded down $0.12 during mid-day trading on Friday, reaching $99.63. The stock had a trading volume of 727,519 shares, compared to its average volume of 258,876. The firm has a market capitalization of $3.12 billion, a price-to-earnings ratio of 28.06, a PEG ratio of 1.89 and a beta of 0.91. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.78 and a current ratio of 1.78. LHC Group has a 52 week low of $67.72 and a 52 week high of $115.54.
About LHC Group
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.
Further Reading: What is diluted earnings per share (Diluted EPS)?
Get a free copy of the Zacks research report on LHC Group (LHCG)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.